Journals / Erciyes Tıp Dergisi / 2009 / Cilt: 31 - Sayı: 4

Prevalence of gestational diabetes among Pregnant Women Attending Erciyes University Medical Faculty

Erciyes Üniversitesi Tıp Fakültesi Hastanesi Kadın Hastalıkları ve Doğum Kliniği’ne başvuran gebelerde gestasyonel diyabet sıklığı

Pages
323–330
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

GDM prevalence of 405 patients according to the Carpanter-Coustan criteria was 11.4% (46 patients), whereas the prevalence according to the National Diabetes Data Group citeria was 6.2% (25 patients).Conclusion: The GDM prevalence at our institution according to the Carpanter-Coustan and National Diabetes Data Group criteria was 11.4% and 6.2%, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to determine the prevalence of gestational diabetes at the obstetrics and gynecology department of the Erciyes University.Patients and Methods: All pregnant women admitted for routine pregnancy follow-up between November 2006 and February 2008 were included in the study.
📊
Key Findings & Data:Each patient received a 100g oral glucose tolerance test between 24 to 28 weeks of gestation.
💡
Conclusion & Impact:GDM prevalence of 405 patients according to the Carpanter-Coustan criteria was 11.4% (46 patients), whereas the prevalence according to the National Diabetes Data Group citeria was 6.2% (25 patients).Conclusion: The GDM prevalence at our institution according to the Carpanter-Coustan and National Diabetes Data Group criteria was 11.4% and 6.2%, respectively.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to determine the prevalence of gestational diabetes at the obstetrics and gynecology department of the Erciyes University.Patients and Methods: All pregnant women admitted for routine pregnancy follow-up between November 2006 and February 2008 were included in the study. Each patient received a 100g oral glucose tolerance test between 24 to 28 weeks of gestation. Maternal age, number of previous pregnancies, parity, weight, height, family history of diabetes and whether they delivered a macrosomic baby (? 4000g) were recorded.Results: Mean maternal age was 28±5.5 (16-44) years. Mean parity was 1.1±1.2 (0-6); 171 patients (42%) were nullipara, 104 were primipara (26%) and 130 (32%) were multipara. The body mass index of the patients before pregnancy and at the time of 100g oral glucose tolerance test was 24.6±4.3 kg/m2 (16.6-40.7) and 27.8±4.3 kg/m2 (17.3-43.1), respectively. GDM prevalence of 405 patients according to the Carpanter-Coustan criteria was 11.4% (46 patients), whereas the prevalence according to the National Diabetes Data Group citeria was 6.2% (25 patients).Conclusion: The GDM prevalence at our institution according to the Carpanter-Coustan and National Diabetes Data Group criteria was 11.4% and 6.2%, respectively.

Özet

Amaç: Sunulan çalışma ile Erciyes Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Kliniği'ne başvuran gebelerde gestasyonel diyabet prevalansının saptanması amaçlandı.Olgular ve Yöntem: Kasım 2006 ile Þubat 2008 tarihleri arasında rutin gebelik takibi için başvuran bütün gebeler çalışmaya dahil edildi. Her bir gebeye 24-28. gebelik haftaları arasında 100g oral glukoz tolerans testi yapıldı. Gebelerin yaşı, gebelik sayısı, paritesi, tartıları ve boyları, makrozomik bebek (? 4000g) doğum öyküsü, ailede diyabet öyküsü ile ilgili hikayesi kaydedildi.Bulgular: Gebelerin yaş ortalaması 28±5,5 (16-44) yıl idi. Gebelerin ortalama paritesi 1,1±1,2 (0-6) olup, 171 gebe (% 42) nullipar, 104 gebe primipar (%26) ve 130 gebe (%32) multipar idi. Gebelerin gebelik öncesi ve 100g oral glukoz tolerans testinin yapıldığı sıradaki vücut-kütle indeksleri sırasıyla 24,6±4,3 kg/m2 (16,6-40,7) ve 27,8±4,3 kg/m2 (17,3-43,1) idi. Çalışmaya alınan 405 gebenin 46'sı (%11,4) ‘Carpanter-Coustan' kriterlerine göre; 25'i (%6,2) ‘National Diabetes Data Group' kriterlerine göre gestasyonel diyabet tanısı aldı.Sonuçlar: Kliniğimize başvuran gebelerde gestasyonel diyabet prevalansı ‘Carpanter-Coustan' kriterlerine göre %11,4, ‘National Diabetes Data Group' kriterlerine göre %6,2 olarak bulundu.

🔖

Cite This Article

BAŞBUĞ, M., BATUKAN, C., ÖZGÜN, M. T., GÜREL, C. (2022). Prevalence of gestational diabetes among Pregnant Women Attending Erciyes University Medical Faculty. Erciyes Tıp Dergisi, Cilt: 31 - Sayı: 4, 323–330. https://ajindex.com/articles/502630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop- Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998; 21 Suppl 2: B161-B167
  2. Harris SB, Caulfield LE, Sugamori ME, Whalen EA, Henning B. The epidemiology of diabetes in pregnant Native Canadians. A risk profile. Diabetes Care 1997; 20: 1422-1425
  3. Mazze RS, Krogh CL. Gestational diabetes mellitus: now is the time for detection and treatment. Mayo Clin Proc 1992; 67: 995-1002
  4. Ozcimen EE, Uckuyu A, Ciftci FC, Yanik FF, Bakar C. Diagnosis of gestational diabetes mellitus by use of the homeostasis model assessment-insulin resistance index in the first trimester. Gynecol Endocrinol 2008; 24: 224-229
  5. Benjamin F, Wilson SJ, Deutsch S, Seltzer VL, Droesch K, Droesch J. Effect of advancing pregnancy on the glucose tolerance test and on the 50-g oral glucose load screening test for gestational diabetes. Obstet Gynecol 1986; 68: 362-365
  6. Ostlund I, Hanson U. Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. Acta Obstet Gynecol Scand 2003; 82: 103-108
  7. Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002; 19: 351-358
  8. Santos-Ayarzagoitia M, Salinas-Martinez AM, Villarreal- Perez JZ. Gestational diabetes: Validity of ADA and WHO diagnostic criteria using NDDG as the reference test. Diabetes Res Clin Pract 2006; 74:322- 9) Kapoor N, Sankaran S, Hyer S, Shehata H. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol 2007; 19: 586-590
  9. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. Jama 1993; 269: 609-615
  10. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985; 2: 7-9
  11. O'Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973; 116: 895-900
  12. Marquette GP, Klein VR, Repke JT, Niebyl JR. Cost- effective criteria for glucose screening. Obstet Gynecol 1985; 66: 181-184
  13. Vidaeff AC, Yeomans ER, Ramin SM. Gestational diabetes: a field of controversy. Obstet Gynecol Surv 2003; 58: 759-769
  14. Di Cianni G, Volpe L, Lencioni C, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 20